Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer Stage Clinical Trial

Official title: Phase II Trial of Neoadjuvant Compound 121564 Plus Platinum Doublet Chemotherapy in Non-Small Cell Lung Cancer

Status Recruiting

Clinical Trial Summary

The purpose of this study is to assess the response rate to neoadjuvant Compound 121564 plus platinum doublet chemotherapy in patients with early stage non-small cell lung cancer.

Clinical Trial Description

Open-label, single-arm multi-center phase II trial of neoadjuvant Compound 121564 plus platinum doublet chemotherapy conducted among patients with early stage (IB, II, IIIA) non-small cell lung cancer. ;

Related Conditions & MeSH terms

• Carcinoma, Non-Small-Cell Lung
• Lung Neoplasms
• Non-Small Cell Lung Cancer Stage

• NCT number: NCT03480230
• Study type: Interventional
• Source: American University of Beirut Medical Center
• Contact: Arafat H Tfayli, MD
• Phone: +961 1 350 000
• Email: at35@aub.edu.lb
• Status: Recruiting
• Phase: Phase 2
• Start date: June 26, 2018
• Completion date: November 2022